| Customization: | Available |
|---|---|
| Powder: | Yes |
| Customized: | Customized |
|
Still deciding? Get samples of US$ 100/Bag
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
Tideglusib (NP-12, NP031112) is a potent, selective and irreversible small molecule non-ATP-competitive glycogen synthase kinase 3 (GSK-3) inhibitor.. Other GSK inhibitors. There are few classes of GSK-inhibitors, including lithium (Martinez et al., 2011), the small peptide L803mts10, and members of the thiazolidinedione family, containing non-competitive inhibitors of GSK-3, such as TDZD-8.Tideglusib is a GSK-3 inhibitor currently in phase II clinical trials for the treatment of Alzheimer disease and progressive supranuclear palsy.
|
Analysis
|
Specification
|
Result
|
Test method
|
|
Physical Description
|
|
|
|
|
Appearance
|
White Powder
|
White Powder |
Visual
|
|
Odor
|
Characteristic
|
Characteristic
|
Organoleptic
|
|
Particle size
|
90% pass 80 mesh
|
90% pass 80 mesh
|
80 Mesh Screen
|
|
Chemical Tests
|
|
|
|
|
Assay (Lutein)
|
99%
|
90.15%
|
HPLC
|
|
Loss on drying
|
5.0% Max
|
1.82%
|
5g/105ºC/2hrs
|
|
Ash Contents
|
5.0% Max
|
1.12%
|
2g/525ºC/3hrs
|
|
Residual Solvents
|
50.0 ppm, Only Ethanol
|
<30.0 ppm
|
/
|
|
Heavy metals
|
5.0 ppm Max
|
<3.0 ppm
|
AAS
|
|
Lead
|
3.0 ppm Max
|
<1.0 ppm
|
AAS
|
|
Arsenic
|
3.0 ppm Max
|
<1.0 ppm
|
AAS
|
|
Microbiology Control
|
|
|
|
|
Total Bacteria Count
|
1,000cfu/g Max
|
<280cfu/g
|
AOAC
|
|
Yeast & Mold
|
100cfu/g Max
|
<10cfu/g
|
AOAC
|
|
Coliform
|
30.0 MPN/g Max
|
<3.0 MPN/g
|
AOAC
|
|
Conclusion
|
Complies with the standards.
|
||
|
General Status
|
Non-GMO, ISO Certificated.
|
||
build up bone mass. An authority reported that was not effective in prevention or treatment of osteoporosis. A double-blind study reveals that ipriflavone might be effective on reducing tinnitus on otosclerosis sufferers.
){kind=link}